Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
NEUP
NEUP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NEUP News
Neuphoria Urges Shareholders to Support Director Nominees for Maximum Value
Dec 08 2025
Newsfilter
Nasdaq Rises 1%; Procter & Gamble Reports Positive Earnings
Oct 24 2025
Benzinga
Tuesday's Major Stock Market Highlights: Morning News Summary!
Oct 21 2025
TipRanks
What Caused Neuphoria Therapeutics Stock (NEUP) to Drop 65% Today?
Oct 21 2025
TipRanks
Neuphoria Therapeutics Shares Progress on AFFIRM-1 Phase 3 Trial Assessing BNC210 for Treating Acute Social Anxiety Disorder
Oct 20 2025
Newsfilter
Neuphoria Therapeutics Inc. Sees Decrease in Annual Loss
Sep 30 2025
NASDAQ.COM
IMRX Rises on Pancreatic Cancer Findings, PEPG Achieves DM1 Splicing Correction Milestone, CLPT Under Observation
Sep 25 2025
NASDAQ.COM
Maxim Group Reaffirms Buy Rating for Neuphoria Therapeutics and Increases Price Target to $35
Sep 11 2025
Benzinga
Neuphoria Therapeutics Achieves Target Enrollment for Phase 3 AFFIRM-1 Study of BNC-210 in Treating Social Anxiety Disorder (SAD)
Sep 04 2025
Newsfilter
HC Wainwright & Co. Affirms Buy Rating for Neuphoria Therapeutics, Keeps $21 Price Target Intact
Aug 26 2025
Benzinga
Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
May 27 2025
Newsfilter
Neuphoria Therapeutics Inc. Reports Q1 2025 Progress and Upcoming Milestones for BNC210 and MK-1167 Programs
May 20 2025
NASDAQ.COM
Neuphoria Provides First Quarter 2025 Business Updates
May 20 2025
Newsfilter
Neuphoria Provides a Review of 2024 and Highlights 2025 Plans
Apr 15 2025
Newsfilter
Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025
Mar 03 2025
Newsfilter
Neuphoria Therapeutics shares surge on $15M Merck payment By Investing.com
Feb 12 2025
Investing.com
Show More News
